Achievement of higher thresholds of clinical responses and lower levels of disease activity is associated with improvements in workplace and household productivity in patients with axial spondyloarthritis.

Rudwaleit, Martin; Machado, Pedro M; Taieb, Vanessa; de Peyrecave, Natasha; Hoepken, Bengt; Gensler, Lianne S

Rudwaleit, Martin; Machado, Pedro M; Taieb, Vanessa; de Peyrecave, Natasha; Hoepken, Bengt; Gensler, Lianne S.

Afiliação

Rudwaleit M; Klinikum Bielefeld, Universitätsklinik für Innere Medizin und Rheumatologie, An der Rosenhöhe 27, 33647 Bielefeld, Germany.
Machado PM; Centre for Rheumatology & Department of Neuromuscular Diseases, University College London, London, UK.
Taieb V; Department of Rheumatology, Northwick Park Hospital, London North West University Healthcare NHS Trust, London, UK.
de Peyrecave N; UCB Pharma, Colombes, France.
Hoepken B; UCB Pharma, Brussels, Belgium.
Gensler LS; UCB Pharma, Monheim, Germany.

Ther Adv Musculoskelet Dis ; 15: 1759720X231189079, 2023.

Article em En | MEDLINE | ID: mdl-37663034

Palavras-chave

axial spondyloarthritis; certolizumab pegol; thresholds of clinical response; work productivity

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Ther Adv Musculoskelet Dis Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Alemanha

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google